The landscape of dementia analysis has developed dramatically with the appearance of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent tests that could detect Alzheimer's pathology several years before indicators arise. Even though these technological innovations represent impressive progress in being familiar with neurodegenerative conditions, t... https://rogerw975amx7.wikilinksnews.com/user